Last reviewed · How we verify

Abametapir Lotion 0.74% w/w — Competitive Intelligence Brief

Abametapir Lotion 0.74% w/w (Abametapir Lotion 0.74% w/w) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Metalloproteinase inhibitor (pediculicide). Area: Dermatology / Parasitology.

phase 3 Metalloproteinase inhibitor (pediculicide) Lice metalloproteinases (zinc-dependent enzymes) Dermatology / Parasitology Small molecule Live · refreshed every 30 min

Target snapshot

Abametapir Lotion 0.74% w/w (Abametapir Lotion 0.74% w/w) — Dr. Reddy's Laboratories Limited. Abametapir is a topical pediculicide that inhibits lice metalloproteinases, disrupting their ability to feed and survive on the scalp.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Abametapir Lotion 0.74% w/w TARGET Abametapir Lotion 0.74% w/w Dr. Reddy's Laboratories Limited phase 3 Metalloproteinase inhibitor (pediculicide) Lice metalloproteinases (zinc-dependent enzymes)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Metalloproteinase inhibitor (pediculicide) class)

  1. Dr. Reddy's Laboratories Limited · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Abametapir Lotion 0.74% w/w — Competitive Intelligence Brief. https://druglandscape.com/ci/abametapir-lotion-0-74-w-w. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: